<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.0.5" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
	<title>Comments on: The Low Risk Trade on Dendreon</title>
	<link>http://wmayhem.com/2007/12/14/the-low-risk-trade-on-dendreon/</link>
	<description>Stock market investment advice with specific buy and sell prices</description>
	<pubDate>Fri, 30 Jul 2010 05:25:58 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.0.5</generator>

	<item>
		<title>by: mlgreen8752</title>
		<link>http://wmayhem.com/2007/12/14/the-low-risk-trade-on-dendreon/#comment-727861</link>
		<pubDate>Mon, 21 Sep 2009 07:43:09 +0000</pubDate>
		<guid>http://wmayhem.com/2007/12/14/the-low-risk-trade-on-dendreon/#comment-727861</guid>
					<description>I prefer my pick in Mentor Capital.  Their 20 percent interest in Quantum Immunologics can potentially benefit in stock price gains.  The full report on why this is can be read over several reports published at &lt;a href="http://breastcancerinvesting.com/investor.shtml" rel="nofollow"&gt;Breast Cancer Investing&lt;/a&gt;.</description>
		<content:encoded><![CDATA[